Giving patients the keys: Self-Controlled hospital stays may curb forced admissions

NCT ID NCT06406972

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether allowing people with borderline personality disorder and a history of self-harm to admit themselves for up to three nights (three times per month) reduces the use of compulsory (forced) psychiatric care. Researchers will compare clinics that implement this program at different times, using registry data from over 1,300 participants. The goal is to see if patient-controlled brief admissions can lower involuntary hospitalizations and improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Brief Admission by self-referral (BA) — a patient-controlled, short inpatient stay program
What this could lead to
If effective, this approach could reduce the need for forced hospitalizations and give people more control over their care.
What could go wrong
Previous trials found no clear benefit, and the study relies on comparing clinics over time, which may still be affected by contamination.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

borderline personality disorder Self-Injurious Behavior Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Division of Psychiatry, Region Skåne

    Lund, Skåne County, 22185, Sweden

  • Region Östergötland

    Linköping, 581 91, Sweden

  • Socialstyrelsen

    Stockholm, Stockholm County, SE-106 30, Sweden

  • Statistiska centralbyrån

    Solna, Solna, 171 54, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.